Clinical Trial Update: Effect of Antisecretory Factor, Given as a Food Supplement to Adult Patients With Severe Traumatic Brain Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an antisecretory factor as a food supplement in adults with severe traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Antisecretory Factor (as a food supplement)

Snippet

Sponsor: Peter Siesjö | Conditions: Brain Trauma | Phase 3 | Status: COMPLETED